Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed

Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed

Roche beat first-quarter sales expectations Thursday, while Sanofi's sales report came in mixed. Shares were muted in premarket trades. The post Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed appeared first on Investor's Business Daily.

Roche’s diagnostic sales hit by China pricing reforms

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic importance.The post Roche’s diagnostic sales hit by China pricing reforms appeared first on Medical Device Network.

MADRID, 24 (EUROPA PRESS) The French pharmaceutical company Sanofi closed the first quarter of 2025 with a net profit attributed to 1,872 million euros, which represents an increase of 65.2% compared to the same period of the previous year. The revenues amounted to 9,895 million euros, 10.8% more. Of that figure, the vaccines contributed [...] The Sanofi entrance earns 1,872 million euros in the first trimester, 65.2% more, and maintains annual …

In the first quarter of this year the pharmaceutical group Roche invoiced 15,440 million Swiss francs (16,397 million euros), which is 7.2% more than twelve months ago thanks to the impulse of its pharmaceutical division.

# Roche Reports 6% Sales Growth in Q1 2025, Signaling Strong Momentum and Strategic Vision,

In an era where healthcare innovation is paramount, Roche Holding AG has shown that its momentum is undeterred, even amidst global uncertainties. The Swiss pharmaceutical giant reported a commendable sales growth of 6%''when adjusted for constant exchange rates''during the first quarter of 2025. This positive trajectory reflects not only the strength of Roche's diverse product portfolio but also its commitment to advancing healthcare solutions. …

Basel-based pharmaceutical group Roche managed to improve its revenue in the first quarter. It has renewed its roadmap for the full year.